$YCBD
cbdMD, Inc. Stock $ycbd

$ycbd Overview Financials Valuation SEC Filings Company Website

2023 Q4 Form 10-K Financial Statement

#000143774923035228 Filed on December 22, 2023

Income Statement

Concept	2023 Q4	2023 Q3	2023
Revenue	$5.375M	$5.711M	$24.16M
YoY Change	-11.66%	-27.34%	-31.77%
Cost Of Revenue	$1.818M	$2.162M	$9.178M
YoY Change	-27.79%	-25.21%	-29.76%
Gross Profit	$3.557M	$3.549M	$14.98M
YoY Change	-0.29%	-28.58%	-32.95%
Gross Profit Margin	66.18%	62.14%	62.01%
Selling, General & Admin	$3.426M	$2.969M	$17.54M
YoY Change	-37.06%	-54.72%	-48.44%
% of Gross Profit	96.29%	83.65%	117.09%
Research & Development	$4.630K
YoY Change
% of Gross Profit	0.13%
Depreciation & Amortization	$110.9K	$670.7K	$404.3K
YoY Change	10.74%	47.1%	-57.4%
% of Gross Profit	3.12%	18.9%	2.7%
Operating Expenses	$4.623M	$5.547M	$24.25M
YoY Change	-31.29%	-30.28%	-38.84%
Operating Profit	-$1.066M	-$1.998M	-$22.49M
YoY Change	-73.66%	-33.11%	-71.27%
Interest Expense	-$420.00	-$630.5K	-$636.3K
YoY Change	-101.44%	-2826.95%	3621.05%
% of Operating Profit
Other Income/Expense, Net		-$59.27K	$0.00
YoY Change		-158.18%	-100.0%
Pretax Income	-$996.5K	-$15.87M	-$22.94M
YoY Change	-74.81%	8.51%	-67.27%
Income Tax	$0.00		$0.00
% Of Pretax Income
Net Earnings	-$996.5K	-$15.87M	-$22.94M
YoY Change	-74.81%	8.5%	-67.27%
Net Earnings / Revenue	-18.54%	-277.98%	-94.96%
Basic Earnings Per Share	-$0.67		-$13.32
Diluted Earnings Per Share	-$0.67	-$16.77	-$13.32
COMMON SHARES
Basic Shares Outstanding	2.961M	2.855M	2.022M
Diluted Shares Outstanding			2.022M

Balance Sheet

Concept	2023 Q4	2023 Q3	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$1.505M	$1.798M	$1.798M
YoY Change	-65.43%	-76.71%	-76.71%
Cash & Equivalents	$1.505M	$1.798M	$1.798M
Short-Term Investments
Other Short-Term Assets	$1.205M	$1.003M	$1.003M
YoY Change	-24.11%	-61.23%	-61.23%
Inventory	$3.743M	$4.236M	$4.053M
Prepaid Expenses
Receivables	$576.9K	$585.3K	$1.216M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$7.366M	$8.070M	$8.070M
YoY Change	-36.11%	-49.6%	-49.6%
LONG-TERM ASSETS
Property, Plant & Equipment	$790.3K	$716.6K	$4.067M
YoY Change	-12.24%	-12.96%	-23.27%
Goodwill		$0.00
YoY Change
Intangibles	$3.046M	$3.219M
YoY Change	-82.65%	-81.95%
Long-Term Investments	$700.0K	$700.0K	$700.0K
YoY Change	-50.0%	-50.0%	-50.0%
Other Assets	$132.2K	$138.7K	$138.7K
YoY Change	-4.69%	-43.29%	-43.29%
Total Long-Term Assets	$7.729M	$8.125M	$8.125M
YoY Change	-68.06%	-67.21%	-67.21%
TOTAL ASSETS
Total Short-Term Assets	$7.366M	$8.070M	$8.070M
Total Long-Term Assets	$7.729M	$8.125M	$8.125M
Total Assets	$15.10M	$16.20M	$16.20M
YoY Change	-57.75%	-60.3%	-60.3%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.567M	$1.906M	$1.906M
YoY Change	-7.27%	-6.4%	-6.4%
Accrued Expenses	$3.102M	$1.484M	$2.762M
YoY Change	17.06%	-27.97%	-14.75%
Deferred Revenue		$187.8K
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$0.00	$2.490K	$2.490K
YoY Change	-100.0%	-74.09%	-74.09%
Total Short-Term Liabilities	$5.972M	$4.670M	$4.670M
YoY Change	7.55%	-11.64%	-11.64%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$9.00	$10.00
YoY Change		-99.99%	-99.99%
Other Long-Term Liabilities	$2.087M	$2.494M	$2.494M
YoY Change	-41.77%	-36.97%	-36.97%
Total Long-Term Liabilities	$2.087M	$2.494M	$2.494M
YoY Change	-41.77%	-38.91%	-38.91%
TOTAL LIABILITIES
Total Short-Term Liabilities	$5.972M	$4.670M	$4.670M
Total Long-Term Liabilities	$2.087M	$2.494M	$2.494M
Total Liabilities	$8.058M	$7.164M	$7.164M
YoY Change	-11.8%	-23.52%	-23.52%
SHAREHOLDERS EQUITY
Retained Earnings	-$176.4M	-$174.4M
YoY Change	15.74%	18.27%
Common Stock	$2.961K	$2.961K
YoY Change	-95.12%	-95.12%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$7.037M	$9.031M	$9.031M
YoY Change
Total Liabilities & Shareholders Equity	$15.10M	$16.20M	$16.20M
YoY Change	-57.75%	-60.3%	-60.3%

Cashflow Statement

Concept	2023 Q4	2023 Q3	2023
OPERATING ACTIVITIES
Net Income	-$996.5K	-$15.87M	-$22.94M
YoY Change	-74.81%	8.5%	-67.27%
Depreciation, Depletion And Amortization	$110.9K	$670.7K	$404.3K
YoY Change	10.74%	47.1%	-57.4%
Cash From Operating Activities	-$105.9K	-$262.1K	-$4.302M
YoY Change	-94.87%	-86.39%	-71.26%
INVESTING ACTIVITIES
Capital Expenditures	$184.6K	$117.5K	$297.5K
YoY Change	4.1%	23.01%	-56.79%
Acquisitions
YoY Change
Other Investing Activities		$0.00	$1.000M
YoY Change
Cash From Investing Activities	-$184.6K	-$117.5K	$702.5K
YoY Change	4.1%	-223.01%	-202.0%
FINANCING ACTIVITIES
Cash Dividend Paid	$1.001M
YoY Change	0.0%
Common Stock Issuance & Retirement, Net			$2.478M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-$2.501K	-662.8K	-$1.323M
YoY Change	-99.78%	-33.94%	-67.22%
NET CHANGE
Cash From Operating Activities	-$105.9K	-262.1K	-$4.302M
Cash From Investing Activities	-$184.6K	-117.5K	$702.5K
Cash From Financing Activities	-$2.501K	-662.8K	-$1.323M
Net Change In Cash	-$293.0K	-1.042M	-$4.922M
YoY Change	-91.3%	-63.21%	-75.0%
FREE CASH FLOW
Cash From Operating Activities	-$105.9K	-$262.1K	-$4.302M
Capital Expenditures	$184.6K	$117.5K	$297.5K
Free Cash Flow	-$290.5K	-$379.6K	-$4.600M
YoY Change	-87.04%	-81.22%	-70.62%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--09-30
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000
CY2022Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000
CY2023Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	5000000
CY2022Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	5000000
CY2023Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	500000
CY2022Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	500000
CY2023Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	150000000
CY2022Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	150000000
CY2023Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	2960573
CY2023Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	2960573
CY2022Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	1348125
CY2022Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	1348125
CY2023Q3	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	0	usd
CY2023Q3	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	0	usd
CY2022Q3	us-gaap	Goodwill Goodwill	0	usd
CY2023Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	2960573
CY2022Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	1348125
CY2023	dei	Document Type DocumentType	10-K
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-09-30
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity File Number EntityFileNumber	001-38299
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NC
CY2023	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	47-3414576
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	8845 Red Oak Blvd
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	Charlotte
CY2023	dei	Entity Address State Or Province EntityAddressStateOrProvince	NC
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	28217
CY2023	dei	City Area Code CityAreaCode	704
CY2023	dei	Local Phone Number LocalPhoneNumber	445-3060
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	true
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023Q1	dei	Entity Public Float EntityPublicFloat	12717633.18	usd
CY2023Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	2960944
CY2023	dei	Auditor Firm AuditorFirmId	677
CY2023	dei	Auditor Name AuditorName	Cherry Bekaert LLP
CY2023	dei	Auditor Location AuditorLocation	Charlotte, North Carolina
CY2023Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1797860	usd
CY2022Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	6720234	usd
CY2023Q3	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	1216090	usd
CY2022Q3	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	1447831	usd
CY2023Q3	us-gaap	Disposal Group Including Discontinued Operation Accounts Notes And Loans Receivable Net DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet	0	usd
CY2022Q3	us-gaap	Disposal Group Including Discontinued Operation Accounts Notes And Loans Receivable Net DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet	1375	usd
CY2023Q3	us-gaap	Other Short Term Investments OtherShortTermInvestments	0	usd
CY2022Q3	us-gaap	Other Short Term Investments OtherShortTermInvestments	1000000	usd
CY2023Q3	us-gaap	Inventory Gross InventoryGross	4052972	usd
CY2022Q3	us-gaap	Inventory Gross InventoryGross	4255914	usd
CY2023Q3	ycbd	Prepaid Inventory PrepaidInventory	182675	usd
CY2022Q3	ycbd	Prepaid Inventory PrepaidInventory	511459	usd
CY2023Q3	ycbd	Prepaid Sponsorship PrepaidSponsorship	70061	usd
CY2022Q3	ycbd	Prepaid Sponsorship PrepaidSponsorship	1372845	usd
CY2023Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	750383	usd
CY2022Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	701945	usd
CY2023Q3	us-gaap	Assets Current AssetsCurrent	8070041	usd
CY2022Q3	us-gaap	Assets Current AssetsCurrent	16011603	usd
CY2023Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	716579	usd
CY2022Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	823310	usd
CY2023Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	3350865	usd
CY2022Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	4477841	usd
CY2023Q3	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	138708	usd
CY2022Q3	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	244606	usd
CY2023Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	3219090	usd
CY2022Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	17834549	usd
CY2023Q3	us-gaap	Other Long Term Investments OtherLongTermInvestments	700000	usd
CY2022Q3	us-gaap	Other Long Term Investments OtherLongTermInvestments	1400000	usd
CY2023Q3	us-gaap	Other Assets OtherAssets	8125242	usd
CY2022Q3	us-gaap	Other Assets OtherAssets	24780306	usd
CY2023Q3	us-gaap	Assets Assets	16195283	usd
CY2022Q3	us-gaap	Assets Assets	40791909	usd
CY2023Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	1906319	usd
CY2022Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	2036558	usd
CY2023Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1484441	usd
CY2022Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	2060762	usd
CY2023Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1277089	usd
CY2022Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1178683	usd
CY2023Q3	us-gaap	Notes Payable Current NotesPayableCurrent	2492	usd
CY2022Q3	us-gaap	Notes Payable Current NotesPayableCurrent	9609	usd
CY2023Q3	us-gaap	Liabilities Current LiabilitiesCurrent	4670341	usd
CY2022Q3	us-gaap	Liabilities Current LiabilitiesCurrent	5285612	usd
CY2023Q3	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	9	usd
CY2022Q3	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	125491	usd
CY2023Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	2403286	usd
CY2022Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	3680375	usd
CY2023Q3	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	90363	usd
CY2022Q3	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	276000	usd
CY2023Q3	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	2493658	usd
CY2022Q3	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	4081866	usd
CY2023Q3	us-gaap	Liabilities Liabilities	7163999	usd
CY2022Q3	us-gaap	Liabilities Liabilities	9367478	usd
CY2023Q3	us-gaap	Preferred Stock Value PreferredStockValue	5000	usd
CY2022Q3	us-gaap	Preferred Stock Value PreferredStockValue	5000	usd
CY2023Q3	us-gaap	Common Stock Value CommonStockValue	2961	usd
CY2022Q3	us-gaap	Common Stock Value CommonStockValue	1348	usd
CY2023Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	183387095	usd
CY2022Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	178841646	usd
CY2023Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-174363772	usd
CY2022Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-147423563	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	9031284	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	31424431	usd
CY2023Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	16195283	usd
CY2022Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	40791909	usd
CY2023	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	25053857	usd
CY2022	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	37122215	usd
CY2023	ycbd	Sales Allowances SalesAllowances	898495	usd
CY2022	ycbd	Sales Allowances SalesAllowances	1718991	usd
CY2023	us-gaap	Revenues Revenues	24155362	usd
CY2022	us-gaap	Revenues Revenues	35403224	usd
CY2023	us-gaap	Cost Of Revenue CostOfRevenue	9177703	usd
CY2022	us-gaap	Cost Of Revenue CostOfRevenue	13066639	usd
CY2023	us-gaap	Gross Profit GrossProfit	14977659	usd
CY2022	us-gaap	Gross Profit GrossProfit	22336585	usd
CY2023	ycbd	Operating Expenses Excluding Impairment OperatingExpensesExcludingImpairment	24246208	usd
CY2022	ycbd	Operating Expenses Excluding Impairment OperatingExpensesExcludingImpairment	39647130	usd
CY2023	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	13219000	usd
CY2022	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	60955970	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-22487549	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-78266515	usd
CY2023	us-gaap	Marketable Securities Gain Loss MarketableSecuritiesGainLoss	-700000	usd
CY2022	us-gaap	Marketable Securities Gain Loss MarketableSecuritiesGainLoss	-33350	usd
CY2023	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	0	usd
CY2022	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	88769	usd
CY2023	us-gaap	Restructuring Charges RestructuringCharges	-0	usd
CY2022	us-gaap	Restructuring Charges RestructuringCharges	602092	usd
CY2023	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-185638	usd
CY2022	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-8473999	usd
CY2023	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	0	usd
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	239250	usd
CY2023	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	63702	usd
CY2022	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	16246	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-22938209	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-70083693	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-0	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-0	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-22938209	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-70083693	usd
CY2023	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	4002000	usd
CY2022	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	4002005	usd
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-26940209	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-74085698	usd
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-13.32
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-55.8
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-13.32
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-55.8
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2022320
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1327784
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2022320
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1327784
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-22938209	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-70083693	usd
CY2023	ycbd	Comprehensive Income Loss Net Of Tax Attributable To Parent Before Income Adjustments ComprehensiveIncomeLossNetOfTaxAttributableToParentBeforeIncomeAdjustments	-22938209	usd
CY2022	ycbd	Comprehensive Income Loss Net Of Tax Attributable To Parent Before Income Adjustments ComprehensiveIncomeLossNetOfTaxAttributableToParentBeforeIncomeAdjustments	-70083693	usd
CY2023	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	4002000	usd
CY2022	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	4002005	usd
CY2023	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-26940209	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-74085698	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-22938209	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-70083693	usd
CY2023	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	233666	usd
CY2022	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	555215	usd
CY2023	us-gaap	Restricted Stock Expense RestrictedStockExpense	109202	usd
CY2022	us-gaap	Restricted Stock Expense RestrictedStockExpense	373610	usd
CY2023	ycbd	Write Off Of Prepaid Assets WriteOffOfPrepaidAssets	884892	usd
CY2022	ycbd	Write Off Of Prepaid Assets WriteOffOfPrepaidAssets	0	usd
CY2023	ycbd	Marketing Stock Amortization MarketingStockAmortization	0	usd
CY2022	ycbd	Marketing Stock Amortization MarketingStockAmortization	907774	usd
CY2023	us-gaap	Inventory Write Down InventoryWriteDown	175499	usd
CY2022	us-gaap	Inventory Write Down InventoryWriteDown	878142	usd
CY2023	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1396459	usd
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	884380	usd
CY2023	us-gaap	Depreciation Depreciation	404280	usd
CY2022	us-gaap	Depreciation Depreciation	948962	usd
CY2023	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	13219000	usd
CY2022	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	60955970	usd
CY2023	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-0	usd
CY2022	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	322017	usd
CY2023	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-185638	usd
CY2022	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-8473999	usd
CY2023	ycbd	Realized And Unrealized Gain Loss On Marketable Securities And Other Securities RealizedAndUnrealizedGainLossOnMarketableSecuritiesAndOtherSecurities	-0	usd
CY2022	ycbd	Realized And Unrealized Gain Loss On Marketable Securities And Other Securities RealizedAndUnrealizedGainLossOnMarketableSecuritiesAndOtherSecurities	-33350	usd
CY2023	ycbd	Otherthantemporary Impairments On Other Investments OtherthantemporaryImpairmentsOnOtherInvestments	700000	usd
CY2022	ycbd	Otherthantemporary Impairments On Other Investments OtherthantemporaryImpairmentsOnOtherInvestments	0	usd
CY2023	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	1126976	usd
CY2022	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	1137119	usd
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-278482	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-65541	usd
CY2023	us-gaap	Increase Decrease In Deposit Other Assets IncreaseDecreaseInDepositOtherAssets	-105898	usd
CY2022	us-gaap	Increase Decrease In Deposit Other Assets IncreaseDecreaseInDepositOtherAssets	-284977	usd
CY2023	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-27443	usd
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	112189	usd
CY2023	ycbd	Increase Decrease In Prepaid Inventory Total IncreaseDecreaseInPrepaidInventoryTotal	-328784	usd
CY2022	ycbd	Increase Decrease In Prepaid Inventory Total IncreaseDecreaseInPrepaidInventoryTotal	-40060	usd
CY2023	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-2095323	usd
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	289586	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-1290141	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-1812547	usd
CY2023	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-1178683	usd
CY2022	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-1151152	usd
CY2023	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	203341	usd
CY2022	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	203341	usd
CY2023	ycbd	Collection On Discontinued Operations Accounts Receivable CollectionOnDiscontinuedOperationsAccountsReceivable	1375	usd
CY2022	ycbd	Collection On Discontinued Operations Accounts Receivable CollectionOnDiscontinuedOperationsAccountsReceivable	9592	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-4302051	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-14967150	usd
CY2023	us-gaap	Proceeds From Sale And Maturity Of Other Investments ProceedsFromSaleAndMaturityOfOtherInvestments	1000000	usd
CY2022	us-gaap	Proceeds From Sale And Maturity Of Other Investments ProceedsFromSaleAndMaturityOfOtherInvestments	0	usd
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	297549	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	688680	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	702451	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-688680	usd
CY2023	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	2478325	usd
CY2022	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	usd
CY2023	us-gaap	Proceeds From Repayments Of Notes Payable ProceedsFromRepaymentsOfNotesPayable	-132599	usd
CY2022	us-gaap	Proceeds From Repayments Of Notes Payable ProceedsFromRepaymentsOfNotesPayable	-33355	usd
CY2023	us-gaap	Payments Of Dividends Preferred Stock And Preference Stock PaymentsOfDividendsPreferredStockAndPreferenceStock	3668500	usd
CY2022	us-gaap	Payments Of Dividends Preferred Stock And Preference Stock PaymentsOfDividendsPreferredStockAndPreferenceStock	4002005	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-1322774	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-4035360	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-4922374	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-19691190	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	6720234	usd
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	26411424	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	1797860	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	6720234	usd
CY2023	us-gaap	Interest Paid Net InterestPaidNet	6399	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	2364	usd
CY2023	ycbd	Preferred Dividends Accrued Not Yet Paid PreferredDividendsAccruedNotYetPaid	667000	usd
CY2022	ycbd	Preferred Dividends Accrued Not Yet Paid PreferredDividendsAccruedNotYetPaid	0	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	31424431	usd
CY2022Q4	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	0	usd
CY2022Q4	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	43449	usd
CY2022Q4	us-gaap	Dividends Preferred Stock Cash DividendsPreferredStockCash	1000502	usd
CY2022Q4	us-gaap	Net Income Loss NetIncomeLoss	-3956062	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	26590761	usd
CY2023Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	0	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	56801	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	1400000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	30000	usd
CY2023Q1	us-gaap	Stock Issued During Period Shares Stock Splits StockIssuedDuringPeriodSharesStockSplits	1
CY2023Q1	us-gaap	Dividends Preferred Stock Cash DividendsPreferredStockCash	1000500	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-1336802	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	25786224	usd
CY2023Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	69615	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	4845	usd
CY2023Q2	ycbd	Stock Issued During Period Value Reverse Stock Splits StockIssuedDuringPeriodValueReverseStockSplits	0	usd
CY2023Q2	us-gaap	Dividends Preferred Stock Cash DividendsPreferredStockCash	1000501	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-1770404	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	25731723	usd
CY2023Q3	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	112	usd
CY2023Q3	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	33171	usd
CY2023Q3	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	3996	usd
CY2023Q3	us-gaap	Dividends Preferred Stock Cash DividendsPreferredStockCash	1000497	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-15874941	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	9031284	usd
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	103142187	usd
CY2021Q4	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	405000	usd
CY2021Q4	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	508754	usd
CY2021Q4	us-gaap	Dividends Preferred Stock Cash DividendsPreferredStockCash	1000502	usd
CY2021Q4	us-gaap	Net Income Loss NetIncomeLoss	-19160904	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	84400000	usd
CY2022Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	661000	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	328515	usd
CY2022Q1	us-gaap	Dividends Preferred Stock Cash DividendsPreferredStockCash	1000500	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-4657216	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	80023429	usd
CY2022Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	178000	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	-593617	usd
CY2022Q2	us-gaap	Dividends Preferred Stock Cash DividendsPreferredStockCash	1000501	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-31634143	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	46600000	usd
CY2022Q3	ycbd	Common Stock Issued During Period Value New Issues CommonStockIssuedDuringPeriodValueNewIssues	198001	usd
CY2022Q3	ycbd	Preferred Stock Issued During Period Value New Issues PreferredStockIssuedDuringPeriodValueNewIssues	128404	usd
CY2022Q3	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	129959	usd
CY2022Q3	us-gaap	Dividends Preferred Stock Cash DividendsPreferredStockCash	1000501	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-14631432	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	31424431	usd
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Use of Estimates</b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The Company's consolidated financial statements have been prepared in accordance with US GAAP and requires management to make estimates and assumptions that affect amounts of assets and liabilities and disclosures of contingent assets and liabilities as of the date of the financial statements and reported amounts of revenues and expenses during the periods presented. Estimates and assumptions are reviewed periodically, and the effects of revisions are reflected in the consolidated financial statements in the period they are determined to be necessary. Significant estimates made in the accompanying consolidated financial statements include, but are <em style="font: inherit;">not</em> limited to, allowances for doubtful accounts, inventory valuation reserves, certain assumptions related to the valuation of investments other securities, and acquired intangible and long-lived assets and the recoverability of intangible and long-lived assets. Actual results could differ from these estimates.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p>
CY2023Q3	us-gaap	Inventory Finished Goods InventoryFinishedGoods	2782680	usd
CY2022Q3	us-gaap	Inventory Finished Goods InventoryFinishedGoods	3198488	usd
CY2023Q3	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	42180	usd
CY2022Q3	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	36980	usd
CY2023Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	585345	usd
CY2023	us-gaap	Property Plant And Equipment Impairment PropertyPlantAndEquipmentImpairment	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Property and Equipment</b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Property and equipment items are stated at cost less accumulated depreciation. Expenditures for routine maintenance and repairs are charged to operations as incurred. Depreciation is charged to expense over the estimated useful lives of the assets using the straight-line method. Generally, the useful lives are <span style="-sec-ix-hidden:c105707370">five</span> years for manufacturing equipment and automobiles and <span style="-sec-ix-hidden:c105707371">three</span> years for software, computer, and furniture and equipment. The useful life for leasehold improvements are over the term of the lease or expected life of the asset, whichever is less. The cost and accumulated depreciation of property are eliminated from the accounts upon disposal, and any resulting gain or loss is included in the consolidated statements of operations for the applicable period. Long-lived assets held and used by the Company are reviewed for impairment whenever changes in circumstance indicate the carrying value of an asset <em style="font: inherit;"> may </em><em style="font: inherit;">not</em> be recoverable.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p>
CY2023Q3	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	1397034	usd
CY2022Q3	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	1213724	usd
CY2023Q3	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	126742	usd
CY2022Q3	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	156298	usd
CY2023Q3	ycbd	Prepaid Inventory PrepaidInventory	182675	usd
CY2022Q3	ycbd	Prepaid Inventory PrepaidInventory	511459	usd
CY2023Q3	us-gaap	Inventory Net InventoryNet	4235647	usd
CY2023	us-gaap	Revenues Revenues	24155362	usd
CY2022	us-gaap	Revenues Revenues	35403224	usd
CY2023	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	6000000	usd
CY2022	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	14300000	usd
CY2022Q3	us-gaap	Inventory Net InventoryNet	4767373	usd
CY2023	us-gaap	Inventory Write Down InventoryWriteDown	175499	usd
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P4Y6M18D
CY2023	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Concentrations</b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Financial instruments that potentially expose the Company to concentrations of credit risk consist primarily of cash and cash equivalents, accounts receivable, and securities.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">The Company places its cash and cash equivalents on deposit with financial institutions in the United States. The Federal Deposit Insurance Corporation (“FDIC”) covers <em style="font: inherit;">$250,000</em> for substantially all depository accounts. The Company from time to time <em style="font: inherit;"> may </em>have amounts on deposit in excess of the insured limits. The Company had a $1,163,360 uninsured balance at <em style="font: inherit;"> September 30, 2023 </em>and a $5,752,550 uninsured balance at <em style="font: inherit;"> September 30, 2022.</em></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Concentration of credit risk with respect to receivables is principally limited to trade receivables with corporate customers that meet specific credit policies. Management considers these customer receivables to represent normal business risk. The Company did <span style="-sec-ix-hidden:c105707458"><span style="-sec-ix-hidden:c105707499">not</span></span> have any customers that represented a significant amount of our sales for the year ended <em style="font: inherit;"> September 30, 2023</em>.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p>
CY2023Q3	us-gaap	Cash Uninsured Amount CashUninsuredAmount	1163360	usd
CY2022Q3	us-gaap	Cash Uninsured Amount CashUninsuredAmount	5752550	usd
CY2023	ycbd	Net Income Loss Including Impairment NetIncomeLossIncludingImpairment	23000000	usd
CY2023	us-gaap	Equity Method Investment Other Than Temporary Impairment EquityMethodInvestmentOtherThanTemporaryImpairment	700000	usd
CY2023	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	13200000	usd
CY2023Q3	ycbd	Net Income Loss Excluding Investment Impairment Charges NetIncomeLossExcludingInvestmentImpairmentCharges	9100000	usd
CY2023Q3	ycbd	Working Capital WorkingCapital	3400000	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	688757	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	660040	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	660040	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	496223	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	22662	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	3219090	usd
CY2023	us-gaap	Marketable Securities Realized Gain Loss MarketableSecuritiesRealizedGainLoss	700000	usd
CY2022	us-gaap	Marketable Securities Realized Gain Loss MarketableSecuritiesRealizedGainLoss	-33350	usd
CY2023Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	2175219	usd
CY2022Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1877671	usd
CY2023Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1458640	usd
CY2022Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1054361	usd
CY2023Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	716579	usd
CY2022Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	823310	usd
CY2023	us-gaap	Depreciation Excluding Lessor Asset Under Operating Lease DepreciationExcludingLessorAssetUnderOperatingLease	404280	usd
CY2022	us-gaap	Depreciation Excluding Lessor Asset Under Operating Lease DepreciationExcludingLessorAssetUnderOperatingLease	948962	usd
CY2023Q3	us-gaap	Goodwill Goodwill	0	usd
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	56.7	usd
CY2023	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	13219000	usd
CY2023Q3	ycbd	Finitelived Intangible Asset Accumulated Impairment FinitelivedIntangibleAssetAccumulatedImpairment	17504000	usd
CY2022Q3	ycbd	Finitelived Intangible Asset Accumulated Impairment FinitelivedIntangibleAssetAccumulatedImpairment	4285000	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	2329321	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	932862	usd
CY2023Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	3219090	usd
CY2022Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	17834549	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	691368	usd
CY2023Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000
CY2023Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q3	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	667000	usd
CY2023Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	150000000
CY2023Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	2960573
CY2022Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	1348125
CY2023Q2	us-gaap	Stock Issued During Period Shares Reverse Stock Splits StockIssuedDuringPeriodSharesReverseStockSplits	39533
CY2021Q4	us-gaap	Stock Issued During Period Shares Restricted Stock Award Gross StockIssuedDuringPeriodSharesRestrictedStockAwardGross	556
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	60101
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	198.9
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	23556
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	43.65
CY2022	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	-0
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	28000
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	163.35
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	55656
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	151.1
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	7233
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	11.51
CY2023	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	-0
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	21124
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	88.12
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	41765
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	144.43
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P3Y7M24D
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	39542
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	151.92
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P3Y8M1D
CY2022	ycbd	Class Of Warrant Or Right Grants In Period ClassOfWarrantOrRightGrantsInPeriod	0
CY2022	ycbd	Class Of Warrant Or Right Grants In Period Weighted Average Exercise Price ClassOfWarrantOrRightGrantsInPeriodWeightedAverageExercisePrice	0
CY2022	ycbd	Class Of Warrant Or Right Exercises In Period ClassOfWarrantOrRightExercisesInPeriod	-0
CY2022	ycbd	Class Of Warrant Or Right Exercises In Period Weighted Average Exercise Price ClassOfWarrantOrRightExercisesInPeriodWeightedAverageExercisePrice	0
CY2022	ycbd	Class Of Warrant Or Right Forfeitures In Period ClassOfWarrantOrRightForfeituresInPeriod	1567
CY2022	ycbd	Class Of Warrant Or Right Forfeitures In Period Weighted Average Exercise Price ClassOfWarrantOrRightForfeituresInPeriodWeightedAverageExercisePrice	242.55
CY2023	ycbd	Class Of Warrant Or Right Grants In Period ClassOfWarrantOrRightGrantsInPeriod	40500
CY2023	ycbd	Class Of Warrant Or Right Grants In Period Weighted Average Exercise Price ClassOfWarrantOrRightGrantsInPeriodWeightedAverageExercisePrice	2.52
CY2023	ycbd	Class Of Warrant Or Right Exercises In Period ClassOfWarrantOrRightExercisesInPeriod	0
CY2023	ycbd	Class Of Warrant Or Right Exercises In Period Weighted Average Exercise Price ClassOfWarrantOrRightExercisesInPeriodWeightedAverageExercisePrice	0
CY2023	ycbd	Class Of Warrant Or Right Forfeitures In Period ClassOfWarrantOrRightForfeituresInPeriod	-3395
CY2023	ycbd	Class Of Warrant Or Right Forfeitures In Period Weighted Average Exercise Price ClassOfWarrantOrRightForfeituresInPeriodWeightedAverageExercisePrice	289.08
CY2023Q3	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	50309
CY2023Q3	ycbd	Class Of Warrant Or Right Outstanding Weighted Average Exercise Price ClassOfWarrantOrRightOutstandingWeightedAverageExercisePrice	37.75
CY2023Q3	ycbd	Class Of Warrant Or Right Outstanding Weighted Average Remaining Contractual Term ClassOfWarrantOrRightOutstandingWeightedAverageRemainingContractualTerm	P4Y25D
CY2023Q3	ycbd	Class Of Warrant Or Right Exercisable ClassOfWarrantOrRightExercisable	50309
CY2023Q3	ycbd	Class Of Warrant Or Right Exercisable Weighted Average Exercise Price ClassOfWarrantOrRightExercisableWeightedAverageExercisePrice	37.75
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-13.32
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-55.8
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-13.32
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-55.8
CY2023	us-gaap	Operating Lease Cost OperatingLeaseCost	1328497	usd
CY2023	us-gaap	Operating Lease Payments OperatingLeasePayments	1380204	usd
CY2023Q3	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P2Y11M26D
CY2023Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0466	pure
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	1421610	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	1159949	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	1372862	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	280565	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	4234986	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	274046	usd
CY2023Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	3960940	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	1421610	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	1159949	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	1372862	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	280565	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	4234986	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	274046	usd
CY2022Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	3960940	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-22938209	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-70083693	usd
CY2023	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	4002000	usd
CY2022	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	4002005	usd
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-26940209	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-74085698	usd
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2022320
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1327784
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2022320
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1327784
CY2023	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	usd
CY2022	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	usd
CY2023	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	0	usd
CY2022	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	0	usd
CY2023	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	0	usd
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	0	usd
CY2023	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	0	usd
CY2022	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	0	usd
CY2023	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	0	usd
CY2022	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	0	usd
CY2023	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	0	usd
CY2022	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	0	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.014	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.004	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	-0.015	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	-0.171	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Other EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther	0.002	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Other EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther	0.025	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.211	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.068	pure
CY2023	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0	pure
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0	pure
CY2023Q3	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	14784000	usd
CY2022Q3	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	12909000	usd
CY2023Q3	ycbd	Right Of Use Liability RightOfUseLiability	824000	usd
CY2022Q3	ycbd	Right Of Use Liability RightOfUseLiability	1087000	usd
CY2023Q3	us-gaap	Deferred Tax Assets Capital Loss Carryforwards DeferredTaxAssetsCapitalLossCarryforwards	702000	usd
CY2022Q3	us-gaap	Deferred Tax Assets Capital Loss Carryforwards DeferredTaxAssetsCapitalLossCarryforwards	702000	usd
CY2023Q3	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	9000	usd
CY2022Q3	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	8000	usd
CY2023Q3	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	521000	usd
CY2022Q3	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	833000	usd
CY2023Q3	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	105000	usd
CY2022Q3	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	0	usd
CY2023Q3	us-gaap	Deferred Tax Assets Investments DeferredTaxAssetsInvestments	180000	usd
CY2022Q3	us-gaap	Deferred Tax Assets Investments DeferredTaxAssetsInvestments	452000	usd
CY2023Q3	us-gaap	Deferred Tax Assets Tax Deferred Expense DeferredTaxAssetsTaxDeferredExpense	87000	usd
CY2022Q3	us-gaap	Deferred Tax Assets Tax Deferred Expense DeferredTaxAssetsTaxDeferredExpense	214000	usd
CY2023Q3	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	45000	usd
CY2022Q3	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	40000	usd
CY2023Q3	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	28000	usd
CY2022Q3	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	35000	usd
CY2023Q3	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	43000	usd
CY2022Q3	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	48000	usd
CY2023Q3	us-gaap	Deferred Tax Assets Charitable Contribution Carryforwards DeferredTaxAssetsCharitableContributionCarryforwards	39000	usd
CY2022Q3	us-gaap	Deferred Tax Assets Charitable Contribution Carryforwards DeferredTaxAssetsCharitableContributionCarryforwards	45000	usd
CY2023Q3	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	17367000	usd
CY2022Q3	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	16373000	usd
CY2023Q3	us-gaap	Deferred Tax Liabilities Prepaid Expenses DeferredTaxLiabilitiesPrepaidExpenses	107000	usd
CY2022Q3	us-gaap	Deferred Tax Liabilities Prepaid Expenses DeferredTaxLiabilitiesPrepaidExpenses	257000	usd
CY2023Q3	us-gaap	Deferred Tax Liabilities Leasing Arrangements DeferredTaxLiabilitiesLeasingArrangements	750000	usd
CY2022Q3	us-gaap	Deferred Tax Liabilities Leasing Arrangements DeferredTaxLiabilitiesLeasingArrangements	1002000	usd
CY2023Q3	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	-0	usd
CY2022Q3	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	3426000	usd
CY2023Q3	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	857000	usd
CY2022Q3	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	4685000	usd
CY2023Q3	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	16510000	usd
CY2022Q3	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	11688000	usd
CY2023Q3	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	16510000	usd
CY2022Q3	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	11688000	usd
CY2023Q3	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	-0	usd
CY2022Q3	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	-0	usd
CY2018Q3	us-gaap	Operating Loss Carryforwards Valuation Allowance OperatingLossCarryforwardsValuationAllowance	2100000	usd
CY2018Q3	ycbd	Deferred Tax Asset And Related Valuation Allowance DeferredTaxAssetAndRelatedValuationAllowance	500000	usd
CY2022Q3	us-gaap	Operating Loss Carryforwards Valuation Allowance OperatingLossCarryforwardsValuationAllowance	11400000	usd
CY2022Q3	ycbd	Deferred Tax Asset And Related Valuation Allowance DeferredTaxAssetAndRelatedValuationAllowance	2700000	usd
CY2023Q3	us-gaap	Operating Loss Carryforwards Valuation Allowance OperatingLossCarryforwardsValuationAllowance	65900000	usd

Files In Submission

Name	View Source	Status
0001437749-23-035228-index-headers.html	Edgar Link	pending
0001437749-23-035228-index.html	Edgar Link	pending
0001437749-23-035228.txt	Edgar Link	pending
0001437749-23-035228-xbrl.zip	Edgar Link	pending
cbdproducts01.jpg	Edgar Link	pending
cbdproducts02.jpg	Edgar Link	pending
ex_568168.htm	Edgar Link	pending
ex_568169.htm	Edgar Link	pending
ex_568170.htm	Edgar Link	pending
ex_568171.htm	Edgar Link	pending
ex_601519.htm	Edgar Link	pending
ex_601519img001.jpg	Edgar Link	pending
ex_601519img002.jpg	Edgar Link	pending
ex_601520.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
ycbd-20230930.xsd	Edgar Link	pending
ycbd20230930_10k.htm	Edgar Link	pending
ycbd_10klogo.jpg	Edgar Link	pending
ycbd-20230930_def.xml	Edgar Link	unprocessable
ycbd-20230930_pre.xml	Edgar Link	unprocessable
ycbd-20230930_lab.xml	Edgar Link	unprocessable
ycbd-20230930_cal.xml	Edgar Link	unprocessable
ycbd20230930_10k_htm.xml	Edgar Link	completed

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$YCBD
cbdMD, Inc. Stock $ycbd

2023 Q4 Form 10-K Financial Statement

#000143774923035228 Filed on December 22, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$YCBD cbdMD, Inc. Stock $ycbd

2023 Q4 Form 10-K Financial Statement

#000143774923035228 Filed on December 22, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$YCBD
cbdMD, Inc. Stock $ycbd